Xponance, Inc. Shockwave Medical, Inc. Transaction History

Xponance, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$191.17 - $325.63 $46,836 - $79,779	-245 Reduced 3.1%	7,656 $2.49 Million
Q4 2023 Jan 31, 2024	SELL	$160.99 - $215.69 $60,371 - $80,883	-375 Reduced 4.53%	7,901 $1.51 Million
Q3 2023 Oct 23, 2023	BUY	$194.33 - $283.97 $6,218 - $9,087	32 Added 0.39%	8,276 $1.65 Million
Q2 2023 Jul 13, 2023	BUY	$223.05 - $302.68 $557,848 - $757,002	2,501 Added 43.55%	8,244 $2.35 Million
Q1 2023 Apr 17, 2023	SELL	$175.41 - $217.92 $2,806 - $3,486	-16 Reduced 0.28%	5,743 $1.25 Million
Q4 2022 Jan 23, 2023	BUY	$204.38 - $296.82 $1,430 - $2,077	7 Added 0.12%	5,759 $0
Q3 2022 Oct 24, 2022	BUY	$195.21 - $310.53 $1,952 - $3,105	10 Added 0.17%	5,752 $1.6 Million
Q2 2022 Aug 02, 2022	BUY	$115.91 - $214.48 $452,049 - $836,472	3,900 Added 211.73%	5,742 $1.1 Million
Q1 2022 Apr 20, 2022	BUY	$127.96 - $207.36 $1,663 - $2,695	13 Added 0.71%	1,842 $382,000
Q4 2021 Jan 31, 2022	BUY	$165.13 - $241.83 $660 - $967	4 Added 0.22%	1,829 $326,000
Q3 2021 Nov 05, 2021	SELL	$163.99 - $235.57 $3,771 - $5,418	-23 Reduced 1.24%	1,825 $376,000
Q2 2021 Aug 12, 2021	BUY	$131.45 - $201.49 $242,919 - $372,353	1,848 New	1,848 $351,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.